type here...

CATEGORIES

Treatments

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

TaiGen files US IND for its influenza antiviral TG-1000

Medika Life -
TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Medika Life -
Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

Eggshell-based surgical material for skull injuries

Medika Life -
A bioactive polymer-ceramic composite for fixing implants and restoring bone defects in the skull was developed by an international group of materials scientists

India: The Growing Focal Point for Health Innovation

Gil Bashe, Medika Life Editor -
India is no longer simply a market to watch. It is a nation shaping the future of global health innovation, a destination for investment,...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories